Epidemiological analysis of influenza vaccination coverage in Pudong New Area, Shanghai (2013-2023): Implications for influenza vaccination strategies.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 Dec 2024
Historique:
medline: 13 10 2024
pubmed: 13 10 2024
entrez: 10 10 2024
Statut: ppublish

Résumé

Seasonal influenza remains a significant public health concern globally, with annual vaccinations as the most effectively preventive measure. This study examines influenza vaccination coverage rates across different age groups in Pudong New Area, Shanghai, China, from 2013 to 2023. This study extracted influenza vaccination data from the Shanghai Immunization Planning Information System (SIPIS) of the Center for Disease Control and Prevention Shanghai's Pudong New Area from 2013 to 2023. The analysis utilized weighted linear regression to compare vaccination rates over the study period. From 2013 to 2023, a cumulative total of 1,421,295 influenza vaccinations were administered in Pudong New Area, with the quadrivalent inactivated influenza vaccines (IIV4) and trivalent inactivated influenza vaccines (IIV3) comprising 56.8% and 42.9%, respectively. The overall average influenza vaccine coverage rate was 2.27% (95% CI: 2.26, 2.28). The 0-4 years group exhibited the highest average annual coverage rate of 22.52% (95% CI: 22.47, 22.57) among different age groups, in stark contrast to that of the 20-24 years age group, which had the lowest at 0.32% (95% CI: 0.31, 0.33). In terms of repeat vaccinations, a significant majority (86.87%) of recipients received only 1-2 doses, while just 13.13% received 3 or more doses. Although influenza vaccination coverage among preschool children in Pudong New Area is relatively high, it falls significantly short of WHO recommendations. Enhance the level of awareness of influenza vaccine among adults and provide a free influenza vaccination strategy for specific groups such as doctors, which is helpful to increase influenza vaccination rates among populations.

Identifiants

pubmed: 39387339
doi: 10.1080/21645515.2024.2412887
doi:

Substances chimiques

Influenza Vaccines 0
Vaccines, Inactivated 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2412887

Auteurs

Pengfei Deng (P)

Department of Immunology, Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai, China.

Caoyi Xue (C)

Department of Immunology, Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai, China.

Tian Yang (T)

Department of Immunology, Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai, China.

Bo Zheng (B)

Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.

Wenmin Liu (W)

Department of Immunology, Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai, China.

Laibao Yang (L)

Department of Immunology, Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai, China.

Yi Fei (Y)

Department of Immunology, Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH